Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |